Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection.
about
Advanced gastric cancer: What we know and what we still have to learnCytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancerFree intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysisIntraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resectionHyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer.Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database.Gastric cancer: current status of diagnosis and treatmentMolecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patientsImpact of Intraoperative Macroscopic Diagnosis of Serosal Invasion in Pathological Subserosal (pT3) Gastric CancerCarcinomatosis from gastrointestinal cancer.Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significanceClinical significance of telomerase activity in peritoneal disseminated cells: gastrointestinal cancersPrognostic value of genetic detection using CEA and MAGE in peritoneal washes with gastric carcinoma after curative resection: result of a 3-year follow-up.S-1 and the treatment of gastric cancer with peritoneal disseminationAnalysis of surgery for incurable gastric cancer.Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer.Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients.Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beadsThe Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study.A proposal of a practical and optimal prophylactic strategy for peritoneal recurrence.Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients.The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art.The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review.Incidence and prognostic significance of positive peritoneal lavage in colorectal cancer.Very early-onset peritoneal recurrence following curative total gastrectomy for Borrmann 4 gastric cancerConventional cytology is not beneficial for predicting peritoneal recurrence after curative surgery for gastric cancer: results of a prospective clinical study.Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysisPeritoneal dissemination in early gastric cancer: importance of the lymphatic route.Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.Test execution variation in peritoneal lavage cytology could be related to poor diagnostic accuracy and stage migration in patients with gastric cancerAnalysis of exfoliated gastric carcinoma cells attached on surgical supplies.Analysis for the combination expression of CK20, FABP1 and MUC2 is sensitive for the prediction of peritoneal recurrence in gastric cancer.Value of peritoneal cytology in potentially resectable pancreatic cancer.Laparoscopy and peritoneal cytology: important prognostic tools to guide treatment selection in gastric adenocarcinoma.The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting.Accuracy of macroscopic intraoperative diagnosis of serosal invasion and risk of over- and underestimation in gastric carcinoma.Positive Peritoneal Lavage Cytology -Implications for Staging and Management of Gastric Cancer.Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy.Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
P2860
Q26774528-0899078B-5173-4C14-904C-87408315AC02Q26774538-92E2C655-948D-4842-9482-472EF5A7BCCBQ26783309-663490BF-37EF-45C2-A321-17160C64439BQ33738960-52657FC9-8FEF-4726-A6F1-7CF91B5CD70CQ33994410-900107EA-E2E1-4DDD-A853-059C9A9E7310Q34573828-7BEF67D9-56AD-4D65-ADDE-4B583506A782Q34657361-1C1989AA-9C80-43AA-8E31-05BABFCAA5B4Q34750564-E4DD39BC-8FCE-410C-AB66-1829402102E4Q34867182-815AA050-3998-4FB3-A562-9EB3B44F14F9Q35682209-8521057F-73A3-4EF0-A29B-85D8E8BFF959Q35812530-27A69DC2-A955-48B5-8052-FBE3A0688F1FQ36101915-4C7C6513-7547-46B0-AC8B-512BBDDE9448Q36193362-CD0E7F11-E16A-4D56-A770-51BF821B6C9CQ36230595-502DCD77-740E-4EE1-97DE-9CEBC7FB9E96Q36383695-ACD6EC27-F0FD-4AD5-B1B2-BE686BA062FFQ36497028-0EA45993-782B-4D56-86DB-7F25387C3442Q36615482-508070A9-6182-45C6-9EA7-F70AFAB31C77Q36621983-4C31DE68-FF56-4386-8E78-9F334732C7CFQ36758921-581B77BD-D033-428D-AF6D-A39C314C0097Q37536724-04B14453-4A20-45A3-ACD8-4BEE484D026DQ38000556-74778C94-1551-40C7-B731-154E0A399A8FQ38018558-1A2F160C-55FE-46F4-BE40-76616C186BC3Q38201470-83949D83-990E-41B3-858F-EF8CDF08CF4AQ38213679-A1232D5D-33C7-4870-8FD4-B7E515632076Q38265361-DEC58CFA-4CFC-4BDF-856D-4AC162885177Q38875138-98529F57-80B9-4B14-B0BC-A6F7B986F71EQ38907751-8BFEA6D4-C619-488A-8BD1-1659507EE578Q39079745-1EA77FC9-5B9C-4B08-A1B6-FAD9D5BEC009Q39739430-FFAA7B0A-F4A4-460D-B553-BBCF64862E04Q41099259-8636FA65-6B8A-43CE-9429-B9BB229D3B13Q41918507-471DB365-EAEE-4DCF-B317-6052657E63B8Q42199133-069812DE-3D28-4959-ABC8-C51777D4CCD3Q43445784-F0A504D4-8B6E-4FA4-A69C-0C9AB7E1DFA5Q43531978-C3124BA0-E02A-45C9-9DBC-F2F9987E3C3DQ44123427-74F381D8-CAA5-41DD-A5C7-A2649BBDD582Q44549744-C490B973-2E83-4E59-A3B2-0C94ACE67CB5Q45392064-5BFE81E0-05E4-41B9-9067-6F9148C976E8Q45797778-F90DAD31-8AF2-464F-B1FC-B89A5686DBF1Q46066281-6CBB8B11-2E22-45E0-8F70-924A39683174Q47312073-E4E94B51-DF56-4F1A-B97C-3613777DA3EC
P2860
Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Peritoneal washing cytology: p ...... otentially curative resection.
@en
type
label
Peritoneal washing cytology: p ...... otentially curative resection.
@en
prefLabel
Peritoneal washing cytology: p ...... otentially curative resection.
@en
P2093
P2860
P1476
Peritoneal washing cytology: p ...... otentially curative resection.
@en
P2093
Morimoto T
Yamamura Y
P2860
P304
60-4; discussion 64-5
P356
10.1002/(SICI)1096-9098(199910)72:2<60::AID-JSO3>3.0.CO;2-1
P577
1999-10-01T00:00:00Z